Judge Delays Part of Trump-Era Drug Rebate Rule Until 2023

Part of a Trump administration rule that targets the drug rebate system is now delayed until 2023, after a pharmacy liaison group argued in court it would significantly disrupt negotiations with drugmakers.

A provision of the Department of Health and Human Services rule (0936-AA08), which changes payments to pharmacy benefit managers such that they can’t fluctuate based on the price of a drug, was slated to take effect January 2022. The effective date is now pushed back by a full year, Judge John D. Bates of the U.S. District Court for the District of Columbia said Jan 30.

The delayed ...